Free Trial
→ Microscopic Footage Shows Immune Cells Attacking Cancer (From Market Tactic) (Ad)tc pixel Free EFC Stock Alerts

Ellington Financial (EFC) Financials

Ellington Financial logo
$13.46 +0.05 (+0.34%)
As of 10:22 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Ellington Financial

Annual Income Statements for Ellington Financial

This table shows Ellington Financial's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 38 -16 34 47 56 17 125 -85 61 118 119
Consolidated Net Income / (Loss)		 38 -16 36 50 63 28 141 -71 88 148 151
Net Income / (Loss) Continuing Operations		 42 -10 32 170 63 28 140 -71 88 148 149
Total Pre-Tax Income 		42 -10 32 0.00 55 1.82 86 -25 89 116 98
Total Revenue		 132 69 60 225 93 47 151 60 277 306 336
Net Interest Income / (Expense)		 98 66 56 214 81 112 131 140 108 136 190
Total Interest Income		 105 80 94 266 160 174 176 282 370 416 494
Investment Securities Interest Income		 105 80 94 266 160 174 176 282 370 416 494
Total Interest Expense		 7.00 14 38 52 78 62 44 142 262 280 305
Long-Term Debt Interest Expense		 - - - 57 - 62 - 142 262 280 305
Total Non-Interest Income		 34 2.73 3.92 0.00 12 -65 20 -80 169 169 146
Other Service Charges		 - - - 4.01 5.35 7.02 7.19 5.38 41 29 52
Net Realized & Unrealized Capital Gains on Investments		 34 2.73 3.92 7.61 6.49 -72 12 -86 128 141 95
Total Non-Interest Expense		 26 28 28 34 39 45 66 85 188 189 239
Salaries and Employee Benefits		 1.90 2.50 2.59 2.65 3.65 3.78 6.71 21 78 69 84
Insurance Policy Acquisition Costs		 - - 0.00 0.72 0.12 0.00 16 - 0.00 0.00 4.53
Other Operating Expenses		 24 26 25 31 31 37 39 58 109 113 140
Other Special Charges		 - - - - 3.54 3.89 5.29 6.29 0.00 7.31 10
Nonoperating Income / (Expense), net		 -64 -51 -0.03 -21 - - 0.00 - 0.00 0.00 -1.38
Income Tax Expense		 - - - 0.00 1.56 11 3.14 -18 0.46 0.61 3.79
Other Gains / (Losses), net		 - - - 0.00 10 38 58 -64 -0.86 32 57
Preferred Stock Dividends Declared		 - - - 0.00 1.47 7.76 8.12 15 23 28 28
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.34 0.31 1.98 3.24 5.24 3.37 7.09 -0.82 3.81 2.24 3.90
Basic Earnings per Share		 $1.13 ($0.48) $1.04 $1.52 $1.76 $0.39 $2.58 ($1.43) $0.89 $1.36 $1.19
Weighted Average Basic Shares Outstanding		 33.70M 32.24M 30.55M 30.70M 44.07M 43.78M 57.48M 68.25M 85.10M 90.68M 124.65M
Weighted Average Diluted Shares Outstanding		 33.70M 32.24M 30.55M 30.70M 44.07M 43.78M 57.48M 68.25M 85.10M 90.68M 124.65M
Weighted Average Basic & Diluted Shares Outstanding		 33.70M 32.24M 30.55M 30.70M 44.07M 43.78M 57.48M 68.25M 85.10M 90.68M 124.65M
Cash Dividends to Common per Share		 $2.45 $1.95 $1.76 $1.64 $1.81 $1.26 $1.64 - $1,800.00 $1,600.00 $1,560.00

Quarterly Income Statements for Ellington Financial

This table shows Ellington Financial's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.59 12 27 52 16 22 32 43 30 15 95
Consolidated Net Income / (Loss)		 13 19 34 60 23 31 39 51 38 23 107
Net Income / (Loss) Continuing Operations		 13 19 34 60 23 31 39 51 38 21 73
Total Pre-Tax Income 		14 17 32 48 16 20 31 35 26 5.76 91
Total Revenue		 54 85 76 91 67 72 83 93 83 77 137
Net Interest Income / (Expense)		 28 28 31 34 34 38 43 43 50 54 61
Total Interest Income		 96 99 102 100 107 107 116 115 123 140 150
Investment Securities Interest Income		 96 99 102 100 107 107 116 115 123 140 150
Total Interest Expense		 69 71 70 67 74 69 73 72 73 87 88
Long-Term Debt Interest Expense		 69 71 70 67 74 69 73 72 73 87 88
Total Non-Interest Income		 26 57 44 58 33 34 40 49 33 25 110
Other Service Charges		 29 2.99 7.51 7.65 1.58 12 24 12 2.56 13 -13
Net Realized & Unrealized Capital Gains on Investments		 -2.55 54 37 50 32 22 15 37 30 11 89
Total Non-Interest Expense		 39 68 44 43 51 52 52 57 57 72 80
Salaries and Employee Benefits		 15 33 15 16 19 19 17 21 22 24 22
Insurance Policy Acquisition Costs		 - - 0.00 0.00 0.00 - 4.53 0.00 0.00 - 19
Other Operating Expenses		 25 35 26 27 30 31 31 33 34 42 37
Other Special Charges		 0.00 - 3.11 0.00 1.99 2.21 0.00 2.28 1.40 6.46 2.32
Income Tax Expense		 0.22 0.13 0.06 0.14 0.01 0.40 -0.10 1.48 1.06 1.35 0.97
Other Gains / (Losses), net		 -0.98 2.55 2.23 12 7.28 11 8.30 17 13 18 18
Preferred Stock Dividends Declared		 5.98 6.11 6.65 6.83 6.83 7.39 7.04 7.04 7.07 6.98 1.92
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.51 0.72 0.48 0.90 0.32 0.55 0.64 1.11 1.18 0.97 2.18
Basic Earnings per Share		 $0.10 $0.17 $0.32 $0.62 $0.19 $0.23 $0.35 $0.45 $0.29 $0.10 $0.78
Weighted Average Basic Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M
Weighted Average Diluted Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M
Weighted Average Basic & Diluted Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M

Annual Cash Flow Statements for Ellington Financial

This table details how cash moves in and out of Ellington Financial's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 70 -61 -76 -2.58 27 39 -19 129 8.68 -22 129
Net Cash From Operating Activities		 654 70 -463 -494 79 120 51 43 -242 -431 -925
Net Cash From Continuing Operating Activities		 654 70 -461 1,842 90 21 94 -41 87 114 92
Net Income / (Loss) Continuing Operations		 38 -16 36 0.00 63 28 141 -71 88 148 151
Consolidated Net Income / (Loss)		 38 -16 36 - 63 28 141 -71 88 148 151
Amortization Expense		 22 25 33 46 -48 -41 -32 -25 -13 4.16 1.80
Non-Cash Adjustments to Reconcile Net Income		 -167 12 -544 1,720 53 32 -86 -12 1.34 -30 -55
Changes in Operating Assets and Liabilities, net		 761 48 13 77 22 1.49 71 67 11 -7.81 -6.18
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00 -1,665 507 -2,025 -1,753 175 -728 -4,066
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00 -1,545 507 -2,025 -1,675 97 134 267
Purchase of Property, Leasehold Improvements and Equipment		 - - - 0.00 -0.24 -0.15 -2,020 -3,591 0.04 0.00 0.00
Purchase of Investment Securities		 - - - 0.00 -11,280 -9,935 -21,962 -40,002 -56 -120 -233
Sale and/or Maturity of Investments		 - - - 0.00 9,733 10,426 21,948 41,848 153 254 500
Net Cash From Financing Activities		 -584 -130 387 492 1,613 -587 1,955 1,839 76 1,137 5,121
Net Cash From Continuing Financing Activities		 -584 -130 387 492 1,492 -587 2,178 1,821 58 -64 119
Issuance of Preferred Equity		 - - - 0.00 111 0.00 116 0.51 97 0.00 0.00
Issuance of Common Equity		 - - - 0.00 157 96 245 99 122 100 302
Repayment of Debt		 -10,254 -5,855 -9,777 -7,713 -8,106 -5,238 -4,825 -12,420 0.00 0.00 0.00
Repurchase of Common Equity		 -5.64 -14 -15 -23 -0.78 -3.06 0.00 -1.66 -12 -0.69 0.00
Payment of Dividends		 -83 -65 -58 -51 -54 -65 -86 -123 -149 -164 -184
Cash Interest Paid		 12 15 28 56 79 66 43 125 263 285 296
Cash Income Taxes Paid		 - - - 0.00 0.19 0.54 2.85 -1.61 -0.32 0.71 1.64

Quarterly Cash Flow Statements for Ellington Financial

This table details how cash moves in and out of Ellington Financial's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -20 54 -37 11 24 -19 8.37 13 -25 133 -147
Net Cash From Operating Activities		 -71 -79 -59 -89 -142 -141 -126 -211 -290 -298 -9.96
Net Cash From Continuing Operating Activities		 -51 40 17 59 70 -31 0.00 55 30 -49 0.00
Net Income / (Loss) Continuing Operations		 13 19 34 60 23 31 0.00 51 38 23 0.00
Net Cash From Investing Activities		 14 296 393 76 -576 -621 -634 -496 -1,023 -1,914 -1,905
Net Cash From Continuing Investing Activities		 -3.66 300 381 57 -597 293 -658 -525 -1,057 2,508 -1,966
Purchase of Property, Leasehold Improvements and Equipment		 -828 2,281 -905 -885 -1,275 3,066 -1,345 -1,489 -1,867 4,701 -2,707
Purchase of Investment Securities		 -9,708 30,175 -8,721 -6,057 -11,350 26,008 -17,269 -17,211 -15,106 49,354 -17,754
Sale and/or Maturity of Investments		 10,492 -32,098 9,956 6,994 12,041 -28,736 17,982 18,197 15,915 -51,594 18,458
Other Investing Activities, net		 41 - 51 4.91 -12 - -26 -22 0.99 - 38
Net Cash From Financing Activities		 37 -163 -370 23 742 743 769 720 1,288 2,344 1,768
Net Cash From Continuing Financing Activities		 35 -39 -385 -53 644 -157 601 544 1,152 -2,179 1,724
Issuance of Debt		 9,172 -30,263 15,634 15,736 18,286 -49,543 18,609 12,917 10,593 - 11,692
Issuance of Common Equity		 15 47 27 - 73 - 51 45 110 97 155
Repayment of Debt		 -9,098 30,202 -15,990 -15,752 -17,673 49,415 -18,018 -12,370 -9,508 39,896 -10,057
Payment of Dividends		 -37 -42 -40 -40 -41 -42 -43 -45 -47 -50 -55
Other Financing Activities, Net		 -16 - -16 3.71 -1.32 - 2.06 -2.14 2.68 - -11
Cash Interest Paid		 68 69 68 75 70 72 76 71 68 80 97
Cash Income Taxes Paid		 0.01 0.14 0.23 0.03 0.03 0.41 0.01 0.42 0.46 0.76 -0.04

Annual Balance Sheets for Ellington Financial

This table presents Ellington Financial's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 2,992 2,413 2,993 3,971 4,338 3,414 5,177 14,086 15,316 16,317 19,353
Cash and Due from Banks		 184 123 47 45 72 112 93 217 229 192 202
Restricted Cash		 4.86 0.66 0.43 0.43 0.18 0.18 0.18 4.82 1.62 17 136
Interest Bearing Deposits at Other Banks		 142 94 140 72 80 63 94 37 52 22 36
Trading Account Securities		 269 36 28 20 2,467 1,530 2,106 1,592 1,662 1,147 1,178
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 2,393 2,160 2,777 5,984 1,719 1,709 2,885 12,235 13,371 14,939 17,801
Total Liabilities & Shareholders' Equity		 2,992 2,413 2,993 3,971 4,338 3,414 5,177 14,086 15,316 16,317 19,353
Total Liabilities		 2,253 1,768 2,372 3,376 3,470 2,492 3,854 12,865 13,780 14,726 17,482
Short-Term Debt		 1,515 1,150 1,450 494 96 34 41 84 162 149 137
Accrued Interest Payable		 - - - 0.00 7.32 3.23 4.57 22 23 18 27
Other Short-Term Payables		 3.63 3.33 3.89 - 6.98 5.74 - - 12 17 19
Long-Term Debt		 0.00 24 268 497 830 892 1,167 2,008 1,943 2,470 3,902
Other Long-Term Liabilities		 734 591 651 2,385 2,529 1,557 2,641 10,751 11,641 12,073 13,396
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 739 645 621 595 869 922 1,324 1,221 1,536 1,591 1,871
Total Preferred & Common Equity		 732 638 600 564 829 885 1,291 1,196 1,517 1,570 1,834
Preferred Stock		 - - - 0.00 111 111 227 227 356 332 332
Total Common Equity		 732 638 600 564 718 774 1,064 969 1,162 1,239 1,502
Common Stock		 732 638 600 564 822 916 0.06 0.06 0.08 0.09 0.11
Retained Earnings		 - - - 0.00 -104 -142 -97 -291 -353 -375 -413
Other Equity Adjustments		 - - - - - - 1,162 1,259 1,515 1,614 1,915
Noncontrolling Interest		 6.90 7.12 21 31 39 36 32 25 19 20 37

Quarterly Balance Sheets for Ellington Financial

This table presents Ellington Financial's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 6,343 14,112 14,303 14,445 15,133 15,093 15,953 16,644 17,072 17,845 20,233
Cash and Due from Banks		 175 189 195 175 187 199 218 203 211 185 163
Restricted Cash		 0.00 1.60 1.60 1.60 6.34 6.10 11 14 20 21 28
Interest Bearing Deposits at Other Banks		 87 24 33 39 17 22 16 43 46 41 40
Trading Account Securities		 1,683 1,494 1,632 1,700 1,479 1,290 1,213 1,101 1,099 1,061 1,290
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 4,398 12,403 12,441 12,530 13,443 13,576 14,495 15,283 15,696 16,537 18,712
Total Liabilities & Shareholders' Equity		 6,343 14,112 14,303 14,445 15,133 15,093 15,953 16,644 17,072 17,845 20,233
Total Liabilities		 5,162 12,737 12,958 13,108 13,579 13,519 14,328 15,007 15,382 16,049 18,275
Short-Term Debt		 111 84 108 155 135 158 130 146 155 145 168
Accrued Interest Payable		 12 15 19 20 25 17 21 20 17 21 18
Other Short-Term Payables		 - - - 14 15 15 16 17 17 19 19
Long-Term Debt		 1,870 2,084 1,901 1,895 2,021 2,072 2,377 2,442 2,717 2,655 4,028
Other Long-Term Liabilities		 3,169 10,554 10,931 11,022 11,383 11,256 11,784 12,381 12,476 13,209 14,042
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,181 1,375 1,345 1,337 1,553 1,574 1,626 1,638 1,690 1,796 1,958
Total Preferred & Common Equity		 1,155 1,350 1,323 1,313 1,533 1,553 1,607 1,614 1,666 1,766 1,920
Preferred Stock		 227 324 324 324 356 356 356 332 332 332 221
Total Common Equity		 928 1,026 999 990 1,178 1,197 1,252 1,282 1,334 1,434 1,699
Common Stock		 0.06 0.07 0.07 0.07 0.09 0.09 0.09 0.09 0.10 0.11 0.13
Retained Earnings		 -286 -282 -310 -334 -363 -344 -362 -379 -374 -385 -366
Other Equity Adjustments		 1,213 1,308 1,308 1,323 1,541 1,541 1,614 1,662 1,708 1,818 2,065
Noncontrolling Interest		 25 25 22 24 20 21 18 23 24 30 38

Annual Metrics And Ratios for Ellington Financial

This table displays calculated financial ratios and metrics derived from Ellington Financial's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - - 107,316,429.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 107,316,429.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.40
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 49.83% -47.63% -13.46% 276.90% -58.63% -49.97% 223.70% -60.28% 361.58% 10.37% 10.08%
EBITDA Growth		 137.05% -48.56% -0.87% 264.83% -97.19% -694.82% 232.11% -195.32% 252.35% 58.54% -17.21%
EBIT Growth		 67.97% -61.20% -21.61% 494.18% -71.45% -96.66% 4,547.17% -129.51% 457.25% 30.33% -15.79%
NOPAT Growth		 67.97% -72.84% 11.99% -53.20% 252.06% -118.04% 962.83% -121.20% 607.75% 30.32% -17.48%
Net Income Growth		 -35.90% -140.86% 329.04% 38.78% 26.58% -55.08% 395.32% -150.42% 224.03% 68.50% 1.80%
EPS Growth		 -45.93% -142.48% 316.67% 46.15% 15.79% -77.84% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 208.29% -89.35% -764.25% -6.75% 116.04% 50.80% -57.08% -16.78% -666.60% -78.01% -114.96%
Free Cash Flow Firm Growth		 203.45% -2.55% -205.21% 257.44% -120.26% 59.90% -864.55% -32.76% 70.04% -89.49% -254.09%
Invested Capital Growth		 -14.10% -19.29% 28.57% -32.18% 13.14% 2.94% 37.02% 30.85% 9.90% 15.63% 40.40%
Revenue Q/Q Growth		 14.96% -21.50% -31.23% 168.98% -54.65% 259.33% -17.36% 304.33% 5.13% -3.98% 1.47%
EBITDA Q/Q Growth		 36.35% -18.94% -18.24% 90.65% -96.15% -25.94% -57.32% 1.66% -28.06% 6.55% -15.39%
EBIT Q/Q Growth		 18.99% -14.26% -36.91% 141.01% -66.32% 105.79% -30.96% 50.75% -15.52% 2.88% -13.88%
NOPAT Q/Q Growth		 18.99% -14.26% -36.91% 634.27% 20.15% 60.84% -27.13% 49.79% -17.91% 2.65% -12.81%
Net Income Q/Q Growth		 -2.28% 0.44% 21.10% -15.66% 35.27% 224.46% -16.48% -20.46% -7.85% 8.29% -5.07%
EPS Q/Q Growth		 10.78% -2.13% 20.93% -15.56% 23.94% 145.88% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 416.13% -83.74% -112.22% 34.96% 565.86% 13.16% -46.49% -31.88% -27.01% -16.77% -20.48%
Free Cash Flow Firm Q/Q Growth		 -20.28% 13.21% -1,112.11% 179.35% -110.15% 81.98% -116.29% 17.45% -102.13% 28.21% -353.23%
Invested Capital Q/Q Growth		 -3.03% -6.64% 14.67% -47.20% 18.36% 0.52% 13.56% 4.77% 7.45% 1.87% 28.59%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 96.60% 94.88% 108.67% 105.19% 7.14% -84.86% 34.63% -83.11% 27.43% 39.40% 29.63%
EBIT Margin		 80.07% 59.33% 53.74% 84.72% 58.46% 3.90% 56.03% -41.62% 32.22% 38.04% 29.10%
Profit (Net Income) Margin		 29.12% -22.72% 60.12% 22.14% 67.74% 60.82% 93.06% -118.13% 31.74% 48.46% 44.81%
Tax Burden Percent		 92.60% 155.39% 111.97% 0.00% 115.87% 1,558.32% 164.21% 283.81% 98.53% 127.38% 153.99%
Interest Burden Percent		 39.27% -24.64% 99.92% 0.00% 100.00% 100.00% 101.15% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 2.86% 624.77% 3.67% 0.00% 0.51% 0.53% 3.87%
Return on Invested Capital (ROIC)		 4.33% 1.41% 1.55% 0.77% 3.13% -0.52% 3.77% -0.60% 2.55% 2.95% 1.89%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.32% -1.89% 1.81% 3.34% 4.20% 3.57% 9.21% -3.83% 2.51% 4.32% 3.55%
Return on Net Nonoperating Assets (RNNOA)		 0.70% -3.68% 4.14% 7.44% 5.50% 3.69% 8.76% -4.97% 3.82% 6.53% 6.82%
Return on Equity (ROE)		 5.03% -2.27% 5.68% 8.21% 8.63% 3.17% 12.52% -5.57% 6.38% 9.47% 8.71%
Cash Return on Invested Capital (CROIC)		 19.50% 22.76% -23.45% 39.11% -9.20% -3.42% -27.47% -27.33% -6.88% -11.55% -31.73%
Operating Return on Assets (OROA)		 3.05% 1.52% 1.19% 5.48% 1.31% 0.05% 1.97% -0.26% 0.61% 0.74% 0.55%
Return on Assets (ROA)		 1.11% -0.58% 1.33% 1.43% 1.52% 0.73% 3.27% -0.74% 0.60% 0.94% 0.85%
Return on Common Equity (ROCE)		 4.99% -2.25% 5.56% 7.86% 7.56% 2.64% 10.25% -4.45% 4.93% 7.27% 6.90%
Return on Equity Simple (ROE_SIMPLE)		 5.25% -2.46% 5.99% 8.85% 7.62% 3.21% 10.88% -5.93% 5.79% 9.43% 8.22%
Net Operating Profit after Tax (NOPAT)		 106 29 32 15 53 -9.56 82 -17 89 116 95
NOPAT Margin		 80.07% 41.53% 53.74% 6.67% 56.79% -20.48% 54.59% -29.14% 32.05% 37.84% 28.37%
Net Nonoperating Expense Percent (NNEP)		 4.01% 3.30% -0.26% -2.57% -1.07% -4.10% -5.45% 3.24% 0.04% -1.37% -1.66%
SG&A Expenses to Revenue		 1.44% 3.61% 4.32% 1.17% 3.91% 8.09% 4.45% 35.16% 28.32% 22.49% 24.86%
Operating Expenses to Revenue		 19.93% 40.67% 46.26% 15.28% 41.54% 96.10% 43.97% 141.62% 67.78% 61.96% 70.90%
Earnings before Interest and Taxes (EBIT)		 106 41 32 191 55 1.82 85 -25 89 116 98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 127 66 65 237 6.66 -40 52 -50 76 120 100
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.29 0.34 0.37 0.43 0.50 0.54 0.66 0.58 0.64 0.87 0.95
Price to Tangible Book Value (P/TBV)		 0.29 0.34 0.37 0.43 0.50 0.54 0.66 0.58 0.64 0.87 0.95
Price to Revenue (P/Rev)		 1.62 3.11 3.68 1.08 3.88 9.04 4.63 9.32 2.69 3.52 4.25
Price to Earnings (P/E)		 5.60 0.00 6.48 5.21 6.41 24.46 5.58 0.00 12.24 9.14 12.03
Dividend Yield		 38.38% 29.48% 25.50% 20.26% 16.88% 13.08% 13.48% 19.46% 16.47% 13.47% 11.72%
Earnings Yield		 17.85% 0.00% 15.43% 19.21% 15.59% 4.09% 17.94% 0.00% 8.17% 10.94% 8.31%
Enterprise Value to Invested Capital (EV/IC)		 0.62 0.65 0.76 0.72 0.72 0.71 0.78 0.80 0.81 0.91 0.92
Enterprise Value to Revenue (EV/Rev)		 10.64 17.06 29.60 5.09 13.79 28.29 13.11 44.08 10.63 12.49 16.24
Enterprise Value to EBITDA (EV/EBITDA)		 11.02 17.98 27.24 4.84 193.22 0.00 37.84 0.00 38.73 31.69 54.78
Enterprise Value to EBIT (EV/EBIT)		 13.29 28.75 55.09 6.01 23.59 724.91 23.39 0.00 32.98 32.83 55.79
Enterprise Value to NOPAT (EV/NOPAT)		 13.29 41.07 55.09 76.34 24.28 0.00 24.01 0.00 33.15 33.00 57.23
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.15 16.92 0.00 0.00 16.23 11.05 38.59 61.95 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 2.95 2.54 0.00 1.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.05 1.82 2.77 1.67 1.07 1.00 0.91 1.71 1.37 1.65 2.16
Long-Term Debt to Equity		 0.00 0.04 0.43 0.84 0.96 0.97 0.88 1.64 1.27 1.55 2.09
Financial Leverage		 2.19 1.94 2.28 2.23 1.31 1.03 0.95 1.30 1.52 1.51 1.92
Leverage Ratio		 4.54 3.91 4.27 5.73 5.68 4.33 3.83 7.57 10.67 10.12 10.30
Compound Leverage Factor		 1.78 -0.96 4.27 0.00 5.68 4.33 3.87 7.57 10.67 10.12 10.30
Debt to Total Capital		 67.21% 64.55% 73.45% 62.48% 51.60% 50.12% 47.72% 63.14% 57.82% 62.21% 68.34%
Short-Term Debt to Total Capital		 67.21% 63.23% 62.00% 31.14% 5.35% 1.86% 1.63% 2.53% 4.44% 3.54% 2.32%
Long-Term Debt to Total Capital		 0.00% 1.32% 11.45% 31.34% 46.25% 48.26% 46.08% 60.61% 53.38% 58.67% 66.02%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 6.19% 6.01% 8.96% 6.87% 9.77% 7.89% 5.62%
Noncontrolling Interests to Total Capital		 0.31% 0.39% 0.89% 1.98% 2.20% 1.97% 1.27% 0.75% 0.51% 0.48% 0.62%
Common Equity to Total Capital		 32.48% 35.05% 25.66% 35.55% 40.02% 41.90% 42.05% 29.24% 31.91% 29.42% 25.42%
Debt to EBITDA		 11.88 17.91 26.42 4.18 139.10 -23.38 23.09 -41.95 27.71 21.75 40.51
Net Debt to EBITDA		 9.29 14.59 23.53 3.69 116.22 -18.96 19.53 -36.76 23.99 19.83 36.76
Long-Term Debt to EBITDA		 0.00 0.37 4.12 2.10 124.69 -22.52 22.30 -40.27 25.58 20.51 39.13
Debt to NOPAT		 14.33 40.91 53.44 65.87 17.48 -96.89 14.65 -119.66 23.72 22.64 42.32
Net Debt to NOPAT		 11.21 33.33 47.59 58.10 14.61 -78.58 12.39 -104.86 20.53 20.64 38.40
Long-Term Debt to NOPAT		 0.00 0.84 8.33 33.04 15.67 -93.30 14.15 -114.86 21.90 21.35 40.88
Noncontrolling Interest Sharing Ratio		 0.87% 1.01% 2.21% 4.29% 12.42% 16.64% 18.11% 20.10% 22.73% 23.23% 20.83%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 476 463 -488 768 -155 -62 -601 -799 -239 -453 -1,605
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 33,020.00% 78,108.50% 2.54% 1.19% -653,670.27% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 67.96 33.60 -12.81 14.70 -1.98 -1.01 -13.66 -5.63 -0.91 -1.62 -5.27
Operating Cash Flow to Interest Expense		 93.50 5.05 -12.16 -9.46 1.01 1.94 1.17 0.30 -0.92 -1.54 -3.04
Operating Cash Flow Less CapEx to Interest Expense		 93.50 5.05 -12.16 -9.46 1.01 1.94 -44.72 -25.03 -0.92 -1.54 -3.04
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.04 0.03 0.02 0.06 0.02 0.01 0.04 0.01 0.02 0.02 0.02
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2,254 1,819 2,339 1,586 1,795 1,847 2,531 3,312 3,640 4,210 5,910
Invested Capital Turnover		 0.05 0.03 0.03 0.11 0.06 0.03 0.07 0.02 0.08 0.08 0.07
Increase / (Decrease) in Invested Capital		 -370 -435 520 -753 208 53 684 781 328 569 1,701
Enterprise Value (EV)		 1,405 1,179 1,771 1,149 1,286 1,320 1,979 2,644 2,942 3,817 5,462
Market Capitalization		 213 215 220 243 362 422 699 559 746 1,077 1,428
Book Value per Share		 $21.91 $19.60 $18.81 $18.79 $21.27 $17.68 $18.53 $16.03 $17.02 $13.66 $14.00
Tangible Book Value per Share		 $21.91 $19.60 $18.81 $18.79 $21.27 $17.68 $18.53 $16.03 $17.02 $13.66 $14.00
Total Capital		 2,254 1,819 2,339 1,586 1,795 1,847 2,531 3,312 3,640 4,210 5,910
Total Debt		 1,515 1,174 1,718 991 926 926 1,208 2,092 2,105 2,619 4,039
Total Long-Term Debt		 0.00 24 268 497 830 892 1,167 2,008 1,943 2,470 3,902
Net Debt		 1,184 957 1,530 874 774 751 1,021 1,833 1,822 2,388 3,665
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.24 0.15 2,020 3,591 0.04 0.00 0.00
Net Nonoperating Expense (NNE)		 67 44 -3.82 -35 -10 -38 -58 53 0.86 -32 -55
Net Nonoperating Obligations (NNO)		 1,515 1,174 1,718 991 926 926 1,208 2,092 2,105 2,619 4,039
Total Depreciation and Amortization (D&A)		 22 25 33 46 -48 -41 -32 -25 -13 4.16 1.80
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.13 ($0.48) $1.04 $1.52 $1.76 $0.00 $0.00 ($1.43) $0.89 $1.36 $1.19
Adjusted Weighted Average Basic Shares Outstanding		 33.05M 32.24M 30.55M 29.75M 44.07M 0.00 0.00 68.25M 85.10M 90.68M 124.65M
Adjusted Diluted Earnings per Share		 $1.13 ($0.48) $1.04 $1.52 $1.76 $0.00 $0.00 ($1.43) $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 33.05M 32.24M 30.55M 29.75M 44.07M 0.00 0.00 68.25M 85.10M 90.68M 124.65M
Adjusted Basic & Diluted Earnings per Share		 $1.13 ($0.48) $1.04 $1.52 $1.76 $0.00 $0.00 ($1.43) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 33.05M 32.24M 30.55M 29.75M 44.07M 0.00 0.00 68.25M 85.10M 90.68M 124.65M
Normalized Net Operating Profit after Tax (NOPAT)		 74 29 23 15 56 4.00 88 -13 89 123 105
Normalized NOPAT Margin		 56.05% 41.53% 37.62% 6.67% 60.48% 8.57% 57.96% -21.80% 32.05% 40.22% 31.27%
Pre Tax Income Margin		 31.45% -14.62% 53.69% 0.00% 58.46% 3.90% 56.67% -41.62% 32.22% 38.04% 29.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 15.10 2.97 0.84 3.66 0.69 0.03 1.92 -0.18 0.34 0.42 0.32
NOPAT to Interest Expense		 15.10 2.08 0.84 0.29 0.67 -0.16 1.87 -0.12 0.34 0.41 0.31
EBIT Less CapEx to Interest Expense		 15.10 2.97 0.84 3.66 0.69 0.03 -43.96 -25.50 0.34 0.42 0.32
NOPAT Less CapEx to Interest Expense		 15.10 2.08 0.84 0.29 0.67 -0.16 -44.01 -25.45 0.34 0.41 0.31
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 217.18% -414.90% 160.26% 101.65% 85.97% 229.15% 60.98% -173.65% 169.82% 110.42% 121.79%
Augmented Payout Ratio		 231.85% -504.24% 200.97% 148.00% 87.21% 239.92% 60.98% -175.99% 183.88% 110.88% 121.79%

Quarterly Metrics And Ratios for Ellington Financial

This table displays calculated financial ratios and metrics derived from Ellington Financial's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - 107,316,429.00 124,649,023.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 107,316,429.00 124,649,023.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.21 0.86
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 428.67% 18.99% -4.66% 53.66% 24.65% -14.96% 11.58% 1.52% 23.56% 6.79% 65.57%
EBITDA Growth		 432.22% -89.01% -22.85% 188.63% 12.41% 564.53% 1.32% -26.36% 60.36% -74.60% 83.98%
EBIT Growth		 432.22% -49.21% -22.85% 188.63% 12.41% 19.23% 1.32% -26.36% 60.36% -78.27% 83.98%
NOPAT Growth		 567.15% -53.57% -22.96% 189.22% 14.11% 17.78% 1.83% -29.21% 53.87% -77.68% 189.91%
Net Income Growth		 143.99% -27.92% -23.91% 459.38% 78.31% 58.64% 15.49% -14.98% 61.89% -26.24% 173.35%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -536.68% -186.92% -22.19% -104.38% -99.86% -78.31% -112.57% -137.62% -104.98% -111.76% 92.12%
Free Cash Flow Firm Growth		 77.29% 58.22% 74.03% -72.53% -242.78% -76.48% -256.47% -79.31% 39.71% -208.84% -279.32%
Invested Capital Growth		 7.16% 9.90% 4.73% 13.45% 21.96% 15.63% 13.91% 19.89% 11.22% 40.40% 45.65%
Revenue Q/Q Growth		 -9.42% 57.50% -10.74% 20.67% -26.52% 7.45% 17.12% 9.79% -10.57% -7.13% 78.60%
EBITDA Q/Q Growth		 -14.43% -74.38% 771.44% 51.08% -66.67% 51.46% 32.87% 9.81% -27.43% -76.01% 821.08%
EBIT Q/Q Growth		 -14.43% 18.39% 88.59% 51.08% -66.67% 25.57% 60.26% 9.81% -27.43% -82.98% 1,198.68%
NOPAT Q/Q Growth		 -15.35% 19.36% 89.67% 50.92% -66.60% 23.19% 63.99% 4.92% -27.40% -82.13% 1,938.74%
Net Income Q/Q Growth		 21.80% 47.75% 76.19% 76.42% -61.17% 31.45% 28.27% 29.88% -26.07% -40.11% 375.34%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -63.55% -11.37% 24.69% -49.00% -59.93% 0.64% 10.22% -66.55% -37.96% -2.64% 96.66%
Free Cash Flow Firm Q/Q Growth		 9.07% -46.51% 56.43% -197.23% -80.65% 24.57% 11.99% -49.51% 39.27% -286.43% -8.41%
Invested Capital Q/Q Growth		 1.05% 7.45% 1.90% 2.55% 8.63% 1.87% 0.38% 7.94% 0.77% 28.59% 4.13%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 26.58% 4.32% 42.21% 52.85% 23.97% 33.78% 38.33% 38.34% 31.11% 8.04% 41.45%
EBIT Margin		 26.58% 19.98% 42.21% 52.85% 23.97% 28.01% 38.33% 38.34% 31.11% 5.70% 41.45%
Profit (Net Income) Margin		 24.34% 22.84% 45.08% 65.90% 34.82% 42.60% 46.65% 55.19% 45.63% 29.42% 78.31%
Tax Burden Percent		 91.58% 114.30% 106.79% 124.70% 145.28% 152.08% 127.16% 143.96% 146.67% 392.33% 118.26%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 95.72% 100.00% 100.00% 131.57% 159.76%
Effective Tax Rate		 1.57% 0.76% 0.19% 0.29% 0.07% 1.97% -0.31% 4.16% 4.12% 23.47% 1.06%
Return on Invested Capital (ROIC)		 2.10% 1.58% 3.17% 4.49% 2.03% 2.14% 3.05% 2.77% 2.27% 0.38% 4.93%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.06% 1.70% 3.28% 5.06% 2.35% 2.60% 3.34% 3.44% 2.76% 0.93% 5.45%
Return on Net Nonoperating Assets (RNNOA)		 3.29% 2.59% 4.84% 7.35% 3.61% 3.93% 4.96% 5.38% 4.28% 1.79% 10.28%
Return on Equity (ROE)		 5.40% 4.17% 8.02% 11.84% 5.64% 6.07% 8.01% 8.16% 6.55% 2.17% 15.22%
Cash Return on Invested Capital (CROIC)		 -3.61% -6.88% -2.43% -9.51% -16.79% -11.55% -10.11% -15.68% -8.12% -31.73% -34.22%
Operating Return on Assets (OROA)		 0.67% 0.38% 0.79% 1.10% 0.50% 0.54% 0.76% 0.75% 0.61% 0.11% 0.88%
Return on Assets (ROA)		 0.62% 0.43% 0.84% 1.37% 0.73% 0.82% 0.92% 1.08% 0.90% 0.56% 1.66%
Return on Common Equity (ROCE)		 4.11% 3.22% 6.03% 8.91% 4.26% 4.66% 6.18% 6.33% 5.14% 1.72% 12.62%
Return on Equity Simple (ROE_SIMPLE)		 7.26% 0.00% 5.03% 8.15% 8.51% 0.00% 9.50% 8.67% 8.99% 0.00% 11.40%
Net Operating Profit after Tax (NOPAT)		 14 17 32 48 16 20 32 34 25 4.41 90
NOPAT Margin		 26.16% 19.83% 42.13% 52.69% 23.95% 27.46% 38.45% 36.74% 29.83% 5.74% 65.51%
Net Nonoperating Expense Percent (NNEP)		 0.05% -0.12% -0.10% -0.57% -0.32% -0.46% -0.29% -0.67% -0.49% -0.55% -0.52%
SG&A Expenses to Revenue		 27.31% 39.20% 19.38% 17.94% 28.35% 26.05% 20.10% 23.05% 26.24% 30.76% 15.89%
Operating Expenses to Revenue		 73.42% 80.02% 57.79% 47.15% 76.03% 71.99% 61.67% 61.67% 68.89% 94.30% 58.55%
Earnings before Interest and Taxes (EBIT)		 14 17 32 48 16 20 32 35 26 4.38 57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 3.66 32 48 16 24 32 35 26 6.18 57
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.74 0.64 0.75 0.85 0.89 0.87 0.93 0.91 0.90 0.95 0.86
Price to Tangible Book Value (P/TBV)		 0.74 0.64 0.75 0.85 0.89 0.87 0.93 0.91 0.90 0.95 0.86
Price to Revenue (P/Rev)		 2.78 2.69 3.22 3.33 3.48 3.52 3.79 3.85 3.87 4.25 3.74
Price to Earnings (P/E)		 10.31 12.24 17.97 10.34 10.27 9.14 9.71 10.74 10.15 12.03 8.01
Dividend Yield		 16.69% 16.47% 17.24% 14.38% 13.01% 13.47% 11.88% 12.13% 12.14% 11.72% 13.30%
Earnings Yield		 9.70% 8.17% 5.57% 9.67% 9.73% 10.94% 10.29% 9.31% 9.85% 8.31% 12.48%
Enterprise Value to Invested Capital (EV/IC)		 0.86 0.81 0.86 0.89 0.91 0.91 0.92 0.91 0.91 0.92 0.92
Enterprise Value to Revenue (EV/Rev)		 11.07 10.63 11.71 11.14 11.77 12.49 12.32 13.19 12.67 16.24 14.55
Enterprise Value to EBITDA (EV/EBITDA)		 27.62 38.73 48.10 30.54 33.14 31.69 32.05 38.52 35.64 54.78 45.90
Enterprise Value to EBIT (EV/EBIT)		 27.62 32.98 40.11 30.54 33.14 32.83 33.19 40.06 36.94 55.79 45.90
Enterprise Value to NOPAT (EV/NOPAT)		 26.98 33.15 40.36 30.69 33.24 33.00 33.72 41.32 38.37 57.23 37.16
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.53 1.37 1.39 1.42 1.54 1.65 1.58 1.70 1.56 2.16 2.14
Long-Term Debt to Equity		 1.42 1.27 1.30 1.32 1.46 1.55 1.49 1.61 1.48 2.09 2.06
Financial Leverage		 1.60 1.52 1.48 1.45 1.54 1.51 1.49 1.56 1.55 1.92 1.89
Leverage Ratio		 8.26 10.67 9.99 10.07 10.26 10.12 9.96 9.86 9.88 10.30 10.26
Compound Leverage Factor		 8.26 10.67 9.99 10.07 10.26 10.12 9.53 9.86 9.88 13.56 16.39
Debt to Total Capital		 60.53% 57.82% 58.13% 58.63% 60.66% 62.21% 61.24% 62.96% 60.93% 68.34% 68.18%
Short-Term Debt to Total Capital		 4.58% 4.44% 3.65% 4.15% 3.14% 3.54% 3.44% 3.39% 3.16% 2.32% 2.73%
Long-Term Debt to Total Capital		 55.94% 53.38% 54.48% 54.47% 57.52% 58.67% 57.80% 59.56% 57.77% 66.02% 65.46%
Preferred Equity to Total Capital		 9.56% 9.77% 9.58% 9.35% 8.60% 7.89% 7.86% 7.28% 7.22% 5.62% 3.59%
Noncontrolling Interests to Total Capital		 0.71% 0.51% 0.53% 0.55% 0.45% 0.48% 0.55% 0.53% 0.65% 0.62% 0.62%
Common Equity to Total Capital		 29.21% 31.91% 31.75% 31.47% 30.29% 29.42% 30.35% 29.24% 31.20% 25.42% 27.61%
Debt to EBITDA		 19.42 27.71 32.42 20.05 22.18 21.75 21.41 26.55 23.76 40.51 33.87
Net Debt to EBITDA		 17.38 23.99 29.25 18.01 20.02 19.83 19.26 23.99 21.67 36.76 32.01
Long-Term Debt to EBITDA		 17.95 25.58 30.38 18.63 21.03 20.51 20.21 25.12 22.53 39.13 32.52
Debt to NOPAT		 18.97 23.72 27.20 20.15 22.25 22.64 22.53 28.48 25.58 42.32 27.42
Net Debt to NOPAT		 16.98 20.53 24.54 18.10 20.08 20.64 20.26 25.73 23.33 38.40 25.91
Long-Term Debt to NOPAT		 17.53 21.90 25.50 18.72 21.09 21.35 21.26 26.94 24.26 40.88 26.33
Noncontrolling Interest Sharing Ratio		 23.85% 22.73% 24.73% 24.76% 24.36% 23.23% 22.90% 22.45% 21.51% 20.83% 17.08%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -212 -311 -136 -403 -728 -549 -483 -723 -439 -1,696 -1,839
Operating Cash Flow to CapEx		 -8.56% 0.00% -6.57% -10.01% -11.11% 0.00% -9.40% -14.14% -15.56% 0.00% -0.37%
Free Cash Flow to Firm to Interest Expense		 -3.09 -4.40 -1.92 -6.03 -9.89 -8.01 -6.65 -10.02 -6.00 -19.58 -20.84
Operating Cash Flow to Interest Expense		 -1.03 -1.12 -0.84 -1.32 -1.92 -2.05 -1.74 -2.92 -3.97 -3.44 -0.11
Operating Cash Flow Less CapEx to Interest Expense		 -13.09 31.14 -13.69 -14.56 -19.24 42.63 -20.25 -23.56 -29.50 50.83 -30.79
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,388 3,640 3,710 3,804 4,132 4,210 4,225 4,561 4,596 5,910 6,154
Invested Capital Turnover		 0.08 0.08 0.08 0.09 0.08 0.08 0.08 0.08 0.08 0.07 0.08
Increase / (Decrease) in Invested Capital		 226 328 167 451 744 569 516 757 464 1,701 1,929
Enterprise Value (EV)		 2,917 2,942 3,199 3,397 3,745 3,817 3,873 4,166 4,200 5,462 5,686
Market Capitalization		 733 746 879 1,017 1,109 1,077 1,191 1,215 1,284 1,428 1,463
Book Value per Share		 $14.55 $17.02 $13.84 $14.08 $14.40 $13.66 $14.14 $14.11 $14.35 $14.00 $13.63
Tangible Book Value per Share		 $14.55 $17.02 $13.84 $14.08 $14.40 $13.66 $14.14 $14.11 $14.35 $14.00 $13.63
Total Capital		 3,388 3,640 3,710 3,804 4,132 4,210 4,225 4,561 4,596 5,910 6,154
Total Debt		 2,051 2,105 2,156 2,230 2,507 2,619 2,588 2,871 2,800 4,039 4,196
Total Long-Term Debt		 1,895 1,943 2,021 2,072 2,377 2,470 2,442 2,717 2,655 3,902 4,028
Net Debt		 1,836 1,822 1,945 2,003 2,262 2,388 2,327 2,595 2,554 3,665 3,965
Capital Expenditures (CapEx)		 828 -2,281 905 885 1,275 -3,066 1,345 1,489 1,867 -4,701 2,707
Net Nonoperating Expense (NNE)		 0.98 -2.55 -2.23 -12 -7.28 -11 -6.92 -17 -13 -18 -18
Net Nonoperating Obligations (NNO)		 2,051 2,105 2,156 2,230 2,507 2,619 2,588 2,871 2,800 4,039 4,196
Total Depreciation and Amortization (D&A)		 0.00 -13 0.00 0.00 0.00 4.16 0.00 0.00 0.00 1.80 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.10 $0.17 $0.32 $0.62 $0.19 $0.23 $0.35 $0.45 $0.29 $0.10 $0.78
Adjusted Weighted Average Basic Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 68.23M 85.10M 85.04M 86.93M 90.66M 90.68M 94.51M 99.89M 107.32M 124.65M 125.39M
Normalized Net Operating Profit after Tax (NOPAT)		 14 17 35 48 18 22 23 36 26 9.36 92
Normalized NOPAT Margin		 26.16% 19.83% 46.24% 52.69% 26.92% 30.47% 26.83% 39.10% 31.45% 12.17% 67.19%
Pre Tax Income Margin		 26.58% 19.98% 42.21% 52.85% 23.97% 28.01% 36.69% 38.34% 31.11% 7.50% 66.22%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.21 0.24 0.45 0.72 0.22 0.29 0.44 0.49 0.35 0.05 0.64
NOPAT to Interest Expense		 0.20 0.24 0.45 0.72 0.22 0.29 0.45 0.47 0.34 0.05 1.02
EBIT Less CapEx to Interest Expense		 -11.85 32.50 -12.40 -12.51 -17.10 44.97 -18.07 -20.15 -25.18 54.32 -30.03
NOPAT Less CapEx to Interest Expense		 -11.85 32.50 -12.40 -12.52 -17.10 44.97 -18.07 -20.17 -25.19 54.32 -29.66
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 145.55% 169.82% 201.10% 125.77% 119.34% 110.42% 108.52% 118.28% 111.12% 121.79% 89.57%
Augmented Payout Ratio		 158.50% 183.88% 202.14% 126.31% 119.84% 110.88% 108.63% 118.28% 111.12% 121.79% 89.57%

Financials Breakdown Chart

Key Financial Trends

Ellington Financial (NYSE: EFC) has shown a pattern of growing assets and steady net interest income across the latest four years, with occasional volatility in quarterly earnings and cash flow. The company continues to operate as a balance-sheet lender/investor, relying on interest income and investment gains, while maintaining a sizable equity base and access to debt markets. Below are the most notable trends and observations drawn from the quarterly statements provided (Q1 2025 through Q4 2025, plus earlier years for context).

  • Net interest income has trended higher in 2025, reaching about $53.6 million in Q4 2025 (vs about $38.1 million in Q4 2024 and $49.7 million in Q3 2025). This signals improving net interest margins and ongoing demand for Ellington’s core lending/investment activities.
  • Total assets grew through 2025, rising from roughly $16.6 billion in early 2025 to about $17.84 billion by Q3 2025, indicating expansion of the loan/investment book and overall balance-sheet scale.
  • Net cash from continuing investing activities turned positive in Q4 2025 at roughly $2.51 billion, driven by investment sales/maturities that more than offset purchases. This supports liquidity despite ongoing investment activity.
  • The quarterly dividend per common share remains stable at $0.39, providing a consistent income signal for retail investors and indicating a predictable payout policy across recent quarters.
  • The equity base remains sizeable against liabilities, with Total Equity & Noncontrolling Interests around $1.80 billion and Total Common Equity around $1.43 billion in late 2025, offering a cushion to absorb earnings volatility and potential losses.
  • Cash flow from operating activities has shown variability by quarter (for example, negative net cash from operating activities in Q4 2025 vs. positive results in several prior quarters), suggesting working capital timing and other non-cash effects can drive short-term swings.
  • Financing activity is highly active, with sizable debt issuance and large debt repayments in different quarters. While this demonstrates access to capital markets and active liability management, the net effect on cash flow can be negative in certain periods, reflecting refinancing and repayment cycles rather than simple profitability changes.
  • Long-term debt remains a material component of the liability stack (around $2.65 billion by late 2025), contributing to ongoing leverage typical of a mortgage REIT and implying sensitivity to interest-rate movements and funding costs.
  • Quarterly net income to common shareholders shows volatility (e.g., about $29.5 million in Q3 2025 versus roughly $14.7 million in Q4 2025), highlighting earnings variability that may affect per-share performance and predictability for investors.
  • Interest expense remains sizable relative to interest income in some periods (for example, Q4 2025: total interest expense ~$86.6 million versus net interest income ~$53.6 million), which can compress net interest margins in a rising-rate environment and press quarterly profitability.
05/14/26 10:23 AM ETAI Generated. May Contain Errors.

Ellington Financial Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ellington Financial's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ellington Financial's net income appears to be on an upward trend, with a most recent value of $150.77 million in 2025, rising from $38.43 million in 2015. The previous period was $148.10 million in 2024. See where experts think Ellington Financial is headed by visiting Ellington Financial's forecast page.

Over the last 10 years, Ellington Financial's total revenue changed from $131.98 million in 2015 to $336.44 million in 2025, a change of 154.9%.

Ellington Financial's total liabilities were at $17.48 billion at the end of 2025, a 18.7% increase from 2024, and a 676.1% increase since 2015.

In the past 10 years, Ellington Financial's cash and equivalents has ranged from $44.66 million in 2018 to $228.93 million in 2023, and is currently $201.89 million as of their latest financial filing in 2025.

Over the last 10 years, Ellington Financial's book value per share changed from 21.91 in 2015 to 14.00 in 2025, a change of -36.1%.


Related Companies

Financial statements for NYSE:EFC last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your temporary download link is expiring
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel